Insomniacs who take longer than 14 minutes to fall asleep face a greater risk of hypertension.
The FDA today approved Ivax Pharmaceuticals’ esomeprazole magnesium delayed-release capsules, the first generic version of AstraZeneca’s proton pump inhibitor Nexium, for the treatment of gastroesophageal reflux disease in patients aged >1 year.
The approximately 4% of American adults with bipolar disorder face a litany of challenges, from unpredictable recurrences of hypomanic/manic or depressive episode to poor impulse control.
Kentucky pharmacist Larry Fortenberry had always imagined what he would do in a robbery situation, and he believed that passive, obedient behavior would be the safest bet.
The FDA today approved perindopril arginine and amlodipine tablets for the treatment of hypertension.
Use of anticoagulants in atrial fibrillation patients remains unacceptably low, with some estimates showing that only half of patients receive anticoagulants as indicated by current treatment guidelines.
The FDA has approved parathyroid hormone (Natpara), a once-daily hormonal injection to control low blood calcium levels (hypocalcemia) in patients with hypoparathyroidism.
The FDA’s Anti-Infective Drugs Advisory Committee has recommended the approval of Astellas’ investigational antifungal drug, isavuconazonium, for the treatment of invasive aspergillosis and mucormycosis, which are life-threatening fungal infections primarily found in immunocompromised patients.